Table 1.
General characteristic of NAFLD patients.
| Steatohepatitis (n 20) | Diffuse Steatosis(n 27) | Focal Fatty Liver (n 3) | Controls (n 50) | |
|---|---|---|---|---|
| Age(years) | 54.1 ± 13.2 | 45.1 ± 6.3 | 56.1 ± 3.1 | 43.8 ± 17.5 |
| BMI (kg\m2) | 30.6 ± 1.4 | 34.7 ± 4.5 | 26.7 ± 0.5 | 28.1 ± 5.3* |
| ALT (U\l) | 68.0 ± 12.7 | 69.6 ± 16.2 | 42.0 ± 15.0 | 28.4 ± 1.1* |
| AST (U\l) | 54.1 ± 13.2 | 45.2 ± 6.3 | 68.0 ± 7.0 | 27.3 ± 1.2* |
| GGT | 62.8 ± 9.9 | 53.2 ± 5.9 | 48.0 ± 8.1 | 49.3 ± 8.5 |
| Cholesterol (mg\dl) | 203.8 ± 15.2 | 174.0 ± 13.3 | 167.0 ± 10.2 | 171 ± 10.1 |
| Triglyceride (mg\dl) | 214.0 ± 47.4 | 134.8 ± 15.9 | 73.0 ± 15.2 | 90 ± 10.5 |
| HOMA-IR | 6.2 ± 1.4 | 4.9 ± 0.9 | 1.5 ± 0.8 | 1.4 ± 0.8* |
| USG Steatosis Grade | 2.04 ± 0.01 | 1.87 ± 0.22 | 0 | 0 |
*BMI of healthy controls was lower than steatohepatitis and steatosis patients. Liver function tests, HOMA-IR value were significantly higher in NAFLD groups compared to controls (p < 0.01)